Landscape of cancer genomics and precision oncology in Europe www.thelancet.com/journals/lan... #hvhebron #onco [Text complet]

Balancing benefits, costs, and harms: policy implications of expanding cancer susceptibility testing from genetics clinics to the general population www.sciencedirect.com/science/arti... #hvhebron #onco

Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Genomic features, Association with Neurofibromatosis Type 1, and Progression to Rhabdomyosarcoma www.sciencedirect.com/science/arti... #hvhebron #ap #onco [Text complet]

Plain language summary of the RELATIVITY-098 study results: nivolumab plus relatlimab given after melanoma is removed by surgery. www.tandfonline.com/doi/abs/10.1... #hvhebron #onco [Text complet]

Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real-world study. acsjournals.onlinelibrary.wiley.com/doi/10.1002/... #hvhebron #onco

Clinical trial design for primary brain tumors: a problem-based framework for neuro-oncology practice. www.frontiersin.org/journals/onc... #hvhebron #onco [Text complet]

Reappraisal of Cisplatin vs Carboplatin Treatment for Solid Tumors: An Umbrella Meta-Analysis. jamanetwork.com/journals/jam... #hvhebron #onco [Text complet]

Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study. aacrjournals.org/clincancerre... #hvhebron #onco [Text complet]

Phase 1 study of KHK2455, a long-acting, potent and selective IDO1 inhibitor, in combination with avelumab in patients with locally advanced or metastatic urothelial carcinoma. jitc.bmj.com/content/14/9... #hvhebron #onco [Text complet]

Prevalence of meeting aerobic physical activity and resistance training guidelines in advanced prostate cancer: a descriptive study of racial and regional disparities in the IRONMAN registry. link.springer.com/article/10.1... #hvhebron #onco [Text complet]

Final Biomarker and Efficacy Analyses of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer in a Phase 2 Study www.sciencedirect.com/science/arti... #hvhebron #onco

Lenvatinib en el carcinoma hepatocelular avanzado: posicionamiento actual y perspectivas futuras revistarevisionesencancer.com/articles/001... #hvhebron #onco [Text complet]

Plain language summary of the KRYSTAL-12 study results: adagrasib for non-small cell lung cancer with KRAS(G12C) mutations. www.tandfonline.com/doi/abs/10.1... #hvhebron #onco [Text complet]

A multimodal murmuration for immunotherapy. www.nature.com/articles/s41... #hvhebron #onco

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN) www.thelancet.com/journals/lan... #hvhebron #onco [Text complet]

Validating the biological origin of in vivo fractional intracellular volume from VERDICT-MRI in the prostate. link.springer.com/article/10.1... #hvhebron #onco [Text complet]

Molecular events underlying sarcoma development and progression: the diagnostic relevance.https://www.tandfonline.com/doi/full/10.1080/14737159.2026.2733191 #hvhebron #onco

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC. www.nature.com/articles/s41... #hvhebron #onco [Text complet]

SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC www.sciencedirect.com/science/arti... #hvhebron #onco [Text complet]